Van Den Berg Management I Inc. Boosts Stock Holdings in The Cigna Group (NYSE:CI)

Van Den Berg Management I Inc. increased its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 185.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,131 shares of the health services provider's stock after purchasing an additional 8,532 shares during the period. Van Den Berg Management I Inc.'s holdings in The Cigna Group were worth $3,626,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in CI. Voya Investment Management LLC boosted its stake in The Cigna Group by 28.1% during the 4th quarter. Voya Investment Management LLC now owns 346,992 shares of the health services provider's stock worth $95,818,000 after purchasing an additional 76,050 shares during the last quarter. T. Rowe Price Investment Management Inc. purchased a new position in The Cigna Group in the 4th quarter worth approximately $724,517,000. Long Focus Capital Management LLC purchased a new stake in shares of The Cigna Group in the fourth quarter valued at approximately $4,888,000. Alta Advisers Ltd increased its holdings in shares of The Cigna Group by 15.5% in the fourth quarter. Alta Advisers Ltd now owns 924 shares of the health services provider's stock valued at $255,000 after purchasing an additional 124 shares during the last quarter. Finally, IHT Wealth Management LLC boosted its stake in The Cigna Group by 28.1% during the fourth quarter. IHT Wealth Management LLC now owns 1,491 shares of the health services provider's stock worth $412,000 after buying an additional 327 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

The Cigna Group Stock Down 0.0 %

The Cigna Group stock traded down $0.10 during mid-day trading on Friday, reaching $335.60. 1,400,117 shares of the company's stock were exchanged, compared to its average volume of 1,703,667. The company has a fifty day moving average of $319.82 and a 200-day moving average of $310.44. The company has a market cap of $91.85 billion, a P/E ratio of 27.42, a P/E/G ratio of 0.98 and a beta of 0.51. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the previous year, the business earned $6.79 earnings per share. Sell-side analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be given a $1.51 dividend. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a yield of 1.80%. The Cigna Group's dividend payout ratio (DPR) is presently 49.35%.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the transaction, the chief executive officer now directly owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 4,904 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the sale, the insider now owns 29,421 shares of the company's stock, valued at $9,065,198.52. This trade represents a 14.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock worth $13,603,991 over the last 90 days. Corporate insiders own 0.70% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on CI. Barclays dropped their price objective on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Sanford C. Bernstein downgraded shares of The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price target for the company. in a report on Thursday, February 6th. Wells Fargo & Company lowered their price objective on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a research report on Tuesday, February 4th. Cantor Fitzgerald lifted their target price on The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research report on Thursday, March 20th. Finally, Oppenheimer lowered their price target on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a report on Friday, January 31st. Two investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $373.56.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.